Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals (@TevaUSA) / Twitter
MedinCell's Partner Teva Today Announced Refiling for Approval of mdc-IRM and Confirmed Planned Launch in the U.S. in H1 2023 | Business Wire
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Pharmaceuticals: Making Quality Health Care Accessible
Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets | News Direct
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Teva Pharmaceuticals: Our manufacturing has kept up with Covid disruptions
Teva Pharm expects to start paying U.S. opioid settlement in 2023 - CEO | MarketScreener
Teva Signs an Exclusive WW License Agreement with Modag to Develop Anle138b and Sery433 for Neurodegenerative Disease
Direct Relief, the National Association of Free and Charitable Clinics and Teva Pharmaceuticals Partner to Advance Access to Behavioral Health Services | The National Association of Free & Charitable Clinics
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Teva Tries to Put an End to the Opioid Wars - WSJ
Acino and Teva sign deal to complete acquisition of Mepha's ...
Teva Looks Towards a Sustainable Future | AP News
/cloudfront-us-east-1.images.arcpublishing.com/gray/5ORNVHIZ6FHUHL74IGLVZ6RU4Q.jpg "New York jury holds drug firm Teva liable in opioid crisis")
New York jury holds drug firm Teva liable in opioid crisis
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva's flagship drug Austedo scores new approval at the FDA
Articles with Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva shares surge after announcing global opioid settlement
Teva Announces Appointment of Richard Francis as President and CEO | Business Wire
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
We see a stable U.S. market place for our generics, says Teva Pharma CEO
